Working… Menu

A Feasibility Study of the Impact on Blood Pressure Control of Supplementing Community Pharmacist Services With Structured Information on Blood Pressure and Its Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01939860
Recruitment Status : Completed
First Posted : September 11, 2013
Last Update Posted : December 5, 2017
Information provided by (Responsible Party):
Ejaz Cheema, University of Warwick

Brief Summary:

Hypertension is a major health problem, however its control is unsatisfactory. One of the reasons for such a high prevalence of this disease includes poor patient compliance to treatment. Approximately 30 % of newly diagnosed hypertensive patients stop taking their blood pressure medication by six months and 50% by 12 months.

The UK government is keen to encourage community pharmacists to play an active role in participation of services that can improve patient adherence to their medications. The New Medicines Service (NMS) and targeted Medicines Use Reviews (MUR) are established services which fund community pharmacists to review and explain medicine use to patients, with hypertension a common condition for which advice is given within these schemes. Within these schemes, advice is verbal and unstructured, with no specific written information provided on drugs or the disease being treated.

This study aims to determine whether structured information provided to participants verbally and in writing by community pharmacists about blood pressure and current medicine(s) within NMS and targeted MURs will be retained and will be associated with improved hypertension control. Participants will be recruited from people eligible for NMS and MURs and attending community pharmacies.

Condition or disease Intervention/treatment Phase
Hypertension Other: Written and verbal patient education on hypertension and its treatment Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 56 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Actual Study Start Date : January 2014
Actual Primary Completion Date : June 2014
Actual Study Completion Date : June 2014

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
No Intervention: Usual pharmacy care
Participants will not receive any structured written education on hypertension and its treatment
Experimental: usual pharmacy care plus structured information
Participants will be provided with validated verbal and written information on hypertension and its treatment, including information about class (es) of anti-hypertensive medication(s) used by each patient, and their common side-effects. The written material will be based on validated patient information leaflets from the British Heart Foundation and the Blood Pressure Association.
Other: Written and verbal patient education on hypertension and its treatment

Primary Outcome Measures :
  1. Changes in systolic or diastolic blood pressure [ Time Frame: 1 year (trial would be stopped at 26 weeks if it is not possible to recruit any further participants ]
    Systolic and diastolic blood pressure will be measured and recorded in mm Hg using OMRON blood pressure monitors

Secondary Outcome Measures :
  1. change in the knowledge of hypertension [ Time Frame: one year(trial would be stopped at 26 weeks if it is not possible to recruit any further participants) ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

1)18 or over 2) male or female 3) Have been started on any blood pressure medication

Exclusion Criteria:

1)Patients with English language problems

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01939860

Layout table for location information
United Kingdom
J P Goes chemist
Coventry, United Kingdom
Sponsors and Collaborators
University of Warwick
Layout table for additonal information
Responsible Party: Ejaz Cheema, PhD student, University of Warwick Identifier: NCT01939860    
Other Study ID Numbers: Warwick.123
First Posted: September 11, 2013    Key Record Dates
Last Update Posted: December 5, 2017
Last Verified: December 2017
Additional relevant MeSH terms:
Layout table for MeSH terms
Vascular Diseases
Cardiovascular Diseases